Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 18, 2025 07:17 ET | Source: Gradient Denervation Technologies

Gradient Denervation Technologies annonce son admission au programme consultatif de la FDA sur le cycle de vie complet des produits pour le développement de son système de dénervation de l’artère pulmonaire

PARIS, 18 juin 2025 (GLOBE NEWSWIRE) -- Gradient Denervation Technologies annonce ce jour son admission au programme pilote TAP (Total Product Life Cycle Advisory Program, programme consultatif sur...
June 18, 2025 07:17 ET | Source: Gradient Denervation Technologies

Gradient Denervation Technologies Announces Acceptance into FDA’s Total Product Life Cycle Advisory Program for Development of its Pulmonary Artery Denervation System

PARIS, June 18, 2025 (GLOBE NEWSWIRE) -- Gradient Denervation Technologies announced today that it has been accepted into the Total Product Life Cycle Advisory Program (TAP) Pilot from the U.S. Food...
June 03, 2025 07:19 ET | Source: Research and Markets

Asia-Pacific Pediatric Interventional Cardiology Industry Report 2025-2033: Insights Into Markets, Shares, Companies, Trends, Growth Opportunities and More

Dublin, June 03, 2025 (GLOBE NEWSWIRE) -- The "Asia-Pacific Pediatric Interventional Cardiology Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" has been added to ...
May 19, 2025 07:17 ET | Source: Gradient Denervation Technologies

Gradient Denervation Technologies annonce que son système de dénervation de l’artère pulmonaire a obtenu la désignation de dispositif innovant par la FDA

PARIS, 19 mai 2025 (GLOBE NEWSWIRE) -- Gradient Denervation Technologies a annoncé aujourd’hui que son système de dénervation pulmonaire a reçu la désignation de dispositif innovant de la part de la...
May 19, 2025 07:17 ET | Source: Gradient Denervation Technologies

Gradient Denervation Technologies Announces FDA Breakthrough Designation for Pulmonary Artery Denervation System

PARIS, May 19, 2025 (GLOBE NEWSWIRE) -- Gradient Denervation Technologies announced today the company’s pulmonary denervation system has received Breakthrough Device Designation by the U.S. Food and...
May 02, 2025 04:24 ET | Source: SNS Insider pvt ltd

Pediatric Interventional Cardiology Market Size to Hit USD 5.19 Billion by 2032, Driven by Rising Congenital Heart Defect Cases – SNS Insider

Austin, May 02, 2025 (GLOBE NEWSWIRE) -- Pediatric Interventional Cardiology Market Size & Growth Analysis: According to SNS Insider, the Pediatric Interventional Cardiology Market was valued...
April 24, 2025 09:40 ET | Source: Research and Markets

Intravascular Ultrasound (IVUS) Global Strategic Business Report 2025-2030 - Cumulative Revenues to Cross $1.1 Billion by 2030 Driven by Patients' Growing Preference for MIS

Dublin, April 24, 2025 (GLOBE NEWSWIRE) -- The "Intravascular Ultrasound (IVUS) - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for...
March 19, 2025 12:24 ET | Source: Research and Markets

Pediatric Interventional Cardiology Market Forecast Report and Company Analysis 2025-2033 Featuring Abbott Laboratories, Boston Scientific, General Electric, Medtronic, Siemens, and Cardinal Health

Dublin, March 19, 2025 (GLOBE NEWSWIRE) -- The "Pediatric Interventional Cardiology Market Report by Device Type, Procedure, End Use, Country and Company Analysis 2025 to 2033" report has been added...
March 13, 2025 11:17 ET | Source: Research and Markets

Cardiogenic Shock Market Report 2025: North America & Europe Lead Cardiogenic Shock Market as Demand for ECMO & pVADs Surges

Dublin, March 13, 2025 (GLOBE NEWSWIRE) -- The "Cardiogenic Shock Market: Analysis by Treatment Type, End User, and Region - Growth Trends and Forecast to 2030" report has been added to ...
March 03, 2025 07:32 ET | Source: Stereotaxis, Inc.

Stereotaxis Submits EMAGIN Catheter for Regulatory Clearance as it Pioneers Robotics for Endovascular Surgery

ST. LOUIS, March 03, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced FDA...

Next Page keyboard_arrow_right